Maternal immunizations and the risk of hospitalization for Covid-19 among infants

  • 1. Zambrano LD, Ellington S, Strid P, etc. Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed pregnancy SARS-CoV-2 infection – United States, January 22 – October 3, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:16411647.

  • two. refusal cl, Wallace B, simeone RM, etc. Risk of stillbirth in women with and without COVID-19 during maternity hospitalization – United States, March 2020 – September 2021. MMWR Morb Mortal Wkly Rep 2021; 70:16401645.

  • 3. Butt AA, Chemical H, Al Hal A, etc. Efficacy of SARS-CoV-2 vaccine in the prevention of confirmed infections in pregnant women. J Clin Invest 2021; 131 (23):e153662e153662.

  • 4. Dagan N, Bard N, T, etc. Efficacy of BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nat Med 2021; 27:16931695

  • 5. Lipkind HS, Vasquez-Benitez G., DeSilva M, etc. Getting the COVID-19 vaccine during pregnancy and premature birth or in young children – eight integrated health organizations, United States, December 15, 2020 – July 22, 2021. MMWR Morb Mortal Wkly Rep 2022; 71:2630.

  • 6. Shimabukuro TT, Kim SY, Myers TR, etc. Preliminary results on the safety of mRNA Covid-19 vaccine in pregnant women. N Engl J Med 2021; 384:22732282.

  • 7. Zauche LH, Wallace B, smooths out AN, etc. Risk of receiving mRNA Covid-19 vaccines and spontaneous abortion. N Engl J Med 2021; 385:15331535.

  • 8. Magnus MC, Gjessing HK, Eide H.N., Wilcox AJ, DB fell, Håberg SE. Covid-19 Vaccination during pregnancy and first trimester abortion. N Engl J Med 2021; 385:20082010.

  • 9. Centers for Disease Control and Prevention. COVID-19 vaccines during pregnancy or lactation (https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html).

  • 10. B, Edwards CM, Scheifele DW, Halperin SA. Vaccination against pertussis and influenza during pregnancy: a landscape review. Lancet Infect Dis 2017; 17 (7):e209e222.

  • 11. Aziz-Baumgartner E, Groskopf L., Patel M. Realization of the potential of maternal influenza vaccination. JAMA 2021; 325:22572259.

  • 12. Omer SB. Maternal vaccination. N Engl J Med 2017; 376:12561267.

  • 13. Halasa NB, Olson SM, State MA, etc. Efficacy of maternal immunization with mRNA COVID-19 during pregnancy against COVID-19-related hospitalization in infants <6 months - 17 states, July-January 2022. MMWR Morb Mortal Wkly Rep 2022; 71:264270.

  • 14. Carlsen EØ, Magnus MC, Oakley L., etc. Association of COVID-19 vaccination during pregnancy, SARS-CoV-2 infection in infants. JAMA Intern Med 2022 June 1 (Before epub printing).

  • 15. Mithal LB, Otero S, Shaines E.D., Goldstein J.A., Miller ES. Maternal coronavirus disease during pregnancy 2019 cord blood antibodies after vaccination. Am J Obstet Gynecol 2021; 225:192194.

  • 16. Beharier O., Plitman Mayo R, The ratio of T, etc. Effective transfer of SARS-CoV-2 and BNT162b2 mRNA antibodies to the COVID-19 vaccine from mother to newborn. J Clin Invest 2021; 131:150319150319.

  • 17. Prabhu M, Murphy EA, Dry AC, etc. 2019 Antibody response to coronavirus disease (COVID-19) Messenger messenger RNA vaccination in pregnant women and transplantation of cord blood. Obstet Gynecol 2021; 138:278280.

  • 18. perl SH, Uzan-Yulzari A., Kleiner X, etc. SARS-CoV-2 specific antibodies in breast milk after coVID-19 vaccination in breastfeeding women. JAMA 2021; 325:20132014.

  • 19. Baird J.K., Jensen SM, Urban WJ, Fox BA, Baird J.R.. SARS-CoV-2 antibodies were found in breast milk after vaccination. J Hum Lact 2021; 37:492498.

  • 20. Yang YJ, Murphy EA, Singh S., etc. 2019 Coronavirus Association Pregnancy Association (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and Maternal and Umbilical Antibody Levels of Vaccine Enhancement Dose. Obstet Gynecol 2022; 139:373380.

  • 21. Trostle ME, Aguero-Rosenfeld ME, Roman AS, Lighter JL. High levels of antibodies in the blood of pregnant women vaccinated against COVID-19. Am J Obstet Gynecol MFM 2021; 3:100481100481.

  • 22. Нир О, Schwartz A, Tussia-Cohen S, etc. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among postpartum women treated with BNT162b2 messenger RNA vaccine during pregnancy. Am J Obstet Gynecol MFM 2022; 4:100492100492.

  • 23. Shaok LL, Atyeo CG, Yonker LM, etc. Resistance of antibodies in infants after maternal COVID-19 vaccination or natural infection. JAMA 2022; 327:10871089.

  • 24. Marks KJ, Whitaker M, Agatist N.T., etc. Hospitalization of laboratory-confirmed COVID-19 infants and children aged 0-4 years – COVID-NET, 14 states, March 2020 – February 2022. MMWR Morb Mortal Wkly Rep 2022; 71:429436.

  • 25. Hobbs CV, Woodworth K., Young CC, etc. Frequency, characteristics and complexity of COVID-19 in hospitalized infants. Pediatric Infection Dis J. 2022; 41 (3):e81e86.

  • 26. Molgaard-Nielsen D, Fisher TK, Krause TG, Хвид А. Efficacy of maternal immunization with trivalent inactivated influenza vaccine in pregnant women and their infants. J Intern Med 2019; 286:469480.

  • 27. Olson SM, Newhams MM, Halasa NB, etc. Effectiveness of the flu vaccine, which is life-threatening for children in the United States. Clin Infect Dis 2022 January 13 (Before epub printing).

  • 28. Chua X, Feng S, Lewnard JA, etc. Use of test-negative management to monitor the effectiveness of vaccines: a systematic review of the methodology. epidemiology 2020; 31:4364.

  • 29. Olson SM, Newhams MM, Halasa NB, etc. Efficacy of BNT162b2 vaccine against Critical Covid-19 in adolescents. N Engl J Med 2022; 386:713723.

  • 30. Olson SM, Newhams MM, Halasa NB, etc. Efficacy of Pfizer-BioNTech mRNA vaccination against COVID-19 hospitalization in people aged 12-18 years – United States, June-September 2021. MMWR Morb Mortal Wkly Rep 2021; 70:14831488.

  • 31. Federal Registration Service. Code of Federal Regulations: Time eCFR System. Name 45 (https://www.ecfr.gov/cgi-bin/text-idx?SID=fc043bd2812f0775fa80066558a6bbcf&mc=true&node=pt45.1.46&rgn=div5#se45.1.46_10).

  • 32. Разаги Х, Megany M., pingali C, etc. Vaccination coverage of pregnant women against COVID-19 – Eight Integrated Health Organization, United States, December 14, 2020 – May 8, 2021. MMWR Morb Mortal Wkly Rep 2021; 70:895899.

  • 33. Patel MK, Bergeri I., Bresee JS, etc. Evaluation of the effectiveness of COVID-19 vaccine after administration: A summary of the interim leadership of the World Health Organization. Vaccine 2021; 39:40134024.

  • 34. Centers for Disease Control and Prevention. COVID data controller: option proportions (https://covid.cdc.gov/covid-data-tracker/#variant-proportions).

  • 35. Gray KJ, Bordt EA, A, etc. Response to the 2019 coronavirus vaccine in pregnant and lactating women: a cohort study. Am J Obstet Gynecol 2021; 225 (3):303.e1303.e17.

  • 36. Klein NP, Stockwell MS, M. Demarco, etc. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccine in the provision of emergency care and hospitalization of children and adolescents aged 5-17 years with COVID-19 – VISION Network, 10 States, April 10 – April 22 – 22 -April. Morb Mortal Wkly Rep 2022; 71:352358.

  • 37. Lauren AS, Tenford MW, Chappell JD, etc. Clinical severity and efficacy of mRNA vaccines against Covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: a prospective observational study. BMJ 2022; 376:e069761e069761.

  • 38. Centers for Disease Control and Prevention. Archived summary data: race / ethnicity of pregnant women aged 18-49 years and the percentage of people who received at least one dose of COVID-19 vaccine during pregnancy as of the date reported on the CDC-Vaccine Safety Datalink website, United States | December 20, 2020 – January 20, 2022 (https://data.cdc.gov/Vaccinations/Cumulative-Data-Percent-of-Pregnant-People-aged-18/4ht3-nbmd/data) .

  • 39. Немет И, Klicker L., Lustig Yu, etc. Third BNT162b2 vaccination neutralizes SARS-CoV-2 omicron infection. N Engl J Med 2022; 386:492494.

  • 40. Thompson MG, Natarazhan K., Irving SA, etc. Efficacy of the third dose of mRNA vaccines against COVID-19-related emergency care and hospitalization of adults during delta and omicron variants – VISION Network, 10 States, 10 States, 2021–2022. MMWRb Wkly Rep 2022; 71:139145.

  • Leave a Comment

    Your email address will not be published.